McIlrath & Eck, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.

Quarter-by-quarter ownership
McIlrath & Eck, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$689
-31.1%
5
-28.6%
0.00%
Q1 2021$1,0000.0%70.0%0.00%
Q4 2020$1,0000.0%70.0%0.00%
Q3 2020$1,0000.0%70.0%0.00%
Q2 2020$1,0000.0%70.0%0.00%
-100.0%
Q1 2020$1,0000.0%70.0%0.00%
Q4 2019$1,0000.0%70.0%0.00%
-100.0%
Q3 2019$1,000
-90.0%
7
-91.8%
0.00%
-83.3%
Q2 2019$10,0000.0%850.0%0.01%0.0%
Q1 2019$10,000850.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Evolutionary Tree Capital Management, LLC 68,937$5,138,0003.04%
Avoro Capital Advisors LLC 2,150,000$160,240,0002.77%
Casdin Capital, LLC 550,000$40,992,0001.22%
TOBAM 371,107$27,659,0001.18%
Ikarian Capital, LLC 455,900$33,978,0001.14%
Eventide Asset Management 697,156$51,959,0000.77%
FOX RUN MANAGEMENT, L.L.C. 4,902$365,0000.66%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 31,500$2,348,0000.62%
Sivik Global Healthcare LLC 20,000$1,491,0000.54%
Rock Springs Capital Management LP 328,750$24,502,0000.54%
View complete list of SAREPTA THERAPEUTICS INC shareholders